Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration

Synapse

Volumn 33, Issue 4, 1999, Pages 289-303

  Rodriguez J J ^a   Pickel, V M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Dopamine; Dorsolateral striatum; Glutamate; Neuroleptic; Plasticity; Schizophrenia; Tardive dyskinesia

Indexed keywords

HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; RECEPTOR SUBUNIT;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; EXTRAPYRAMIDAL SYNDROME; GENE EXPRESSION REGULATION; GLIA CELL; IMMUNOGOLD STAINING; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUTAMEN; RAT; RECEPTOR DENSITY;

ANIMALS; ANTIPSYCHOTIC AGENTS; AXONS; CAUDATE NUCLEUS; DENDRITES; FUNCTIONAL LATERALITY; HALOPERIDOL; MALE; MICROSCOPY, IMMUNOELECTRON; N-METHYLASPARTATE; NEUROGLIA; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0344418672     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990915)33:4<289::AID-SYN6>3.0.CO;2-I     Document Type: Article

References (98)

1. Albin RL, Young AB, Penney JB. 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
2. Anglade P, Mouatt-Prigent A, Agid Y, Hirsch EC. 1996. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration 5:121-128.
3. Aoki C, Venkatesan CG, Mong JA, Dawson TM. 1994. Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats. J Neurosci 14:5202-5222.
4. Ariano MA, Larson ER, Noblett KL, Sibley DR, Levine MS. 1997. Coexpression of striatal dopamine receptor subtypes and excitatory amino acids subunits. Synapse 26:400-414.
5. Astzély F, Gustafsson B. 1996. Ionotropic glutamate receptors. Mol Neurobiol 12:1-11.
6. Bading H, Segal MM, Sucher NJ, Dudek H, Lipton SA, Greenberg ME. 1995. N-methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons. Neuroscience 64:653-664.
7. Berridge MJ. 1998. Neuronal calcium signalling. Neuron 21:13-26.
8. Bliss TVP, Collindridge GL. 1993. A synaptic model of memory: long term potentiation in the hippocampus. Nature 361:31-39.
9. Bouyer JJ, Miller RJ, Pickel VM. 1984. Ultrastructural relation between cortical efferents and terminals containing enkephalin-like immunoreactivity in rat neostriatum. Regul Pept 8:105-115.
10. Brooks WJ, Petit TL, LeBouteiller JC. 1997. Effect of chronic administration of NMDA antagonists on synaptic development. Synapse 26:104-113.
11. Bundman MC, Pico RM, Gall CM. 1994. Ultrastructure plasticity of dentate gyrus granule cells following recurrent limbic seizures. I. Increase in somatic spines. Hippocampus 4:601-610.
12. Calabresi P, Saiardi A, Pisani A, Baik JH, Cetonze D, Mercuri NB, Bernardi G, Borrelli E. 1997. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J Neurosci 17:4536-4544.
13. Calverley RKS, Jones DG. 1990a. Three-dimensional computer reconstruction of perforated synapses. In: Conn PM, editor. Quantitative and qualitative microscopy. Orlando, FL: Academic Press. p 136-154.
14. Calverley RKS, Jones DG. 1990b. Determination of numerical density of perforated and non-perforated synapses. In: Conn PM, editor. Quantitative and qualitative microscopy. Orlando, FL: Academic Press. p 155-172.
15. Casey DE. 1987. Tardive dyskinesia. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press. p 1411-1419.
16. Casey DE. 1994. Motor and mental aspects of acute extrapyramidal syndromes. Acta Psychiatr Scand Suppl 380:14-20.
17. Cepeda C, Levine MS. 1998. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev Neurosci 20:1-18.
18. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M. 1994. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151:1430-1436.
19. Chakos M, Lee H, Bilder R, Zhao M, Tamminga C. 1997. Effect of neuroleptic treatment on post-mortem rodent striatal volumes. Schizophr Res 24:140.
20. Chan J, Aoki C, Pickel VM. 1990. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Meth 33:113-127.
21. Cheng HW, Rafols JA, Gosgharian HG, Anavi Y, Tong J McNeill TH. 1997. Differential spine loss and regrowth of striatal neurons following multiple forms of deafferentation: a Golgi study. Exp Neurol 147:287-298.
22. Coggeshall RE, Lekan HA. 1996. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364:6-15.
23. Comery TA, Stamoudis CX, Irwin SA, Greenough WT. 1996. Increased density of multiple-head dendritic spines on medium-sized spiny neurons of the striatum in rats reared in a complex environment. Neurobiol Learn Mem 66:93-96.
24. Conti F, DeBiasi S, Minelli A, Melone M. 1996. Expression of NR1 and NR2A/B subunits of the MNDA receptor in cortical astrocytes. Glia 17:254-258.
25. Creese I. 1983. Classical and atypical antipsychotic drugs: new insights. Trends Neurosci 6:479-481.
26. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HV, Lipton SA, Nakanishi N. 1998. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393:377-381.
27. Davis JM, Metalon M, Watanabe MD, Blake L. 1994. Depot antipsychotic drugs. Drugs 47:741-773.
28. 2 receptor within GABAergic neurons of the rat striatum. Brain Res 746:239-255.
29. DiFiglia M, Pasik T, Pasik P. 1980. Ultrastructure of Golgi-impregnated and gold-toned spiny and aspiny neurons in the monkey neostriatum. J Neurocytol 9:471-492.
30. Donzanti BA, Hite JF, Yamamoto BK. 1993. Extracellular glutamate levels increase with age in the lateral striatum: potential involvement of presynaptic D-2 receptors. Synapse 13:376-382.
31. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ. 1995. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
32. Freund TF, Powell JF, Smith AD. 1984. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13:1189-1215.
33. Geinisman Y, de Tbledo-Morrell L, Morrell F. 1991. Induction of long-term potentiation is associated with an increase in the number of axospinous synapses with segmented postsynaptic densities. Brain Res 566:77-88.
34. Gracy KN, Pickel VM. 1995. Comparative ultrastructural localization of the NMDAR1 glutamate receptor in the rat basolateral amygdala and bed nucleus of the stria terminalis. J Comp Neurol 362:71-85.
35. Gracy KN, Pickel VM. 1996. Ultrastructural immunocytochemical localization of the N-methyl-D-aspartate (NMDA) receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens. Brain Res 739:169-181.
36. Gracy KN, Pickel VM. 1997. Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res 747:259-272.
37. Gracy KN, Svingos AL, Pickel VM. 1997. Dual ultrastructural localization of μ-opioid receptors and MNDA-type glutamate receptors in the shell of the rat nucleus accumbens. J Neurosci 17:4839-4848.
38. Gracy KN, Clarke CL, Meyers MB, Pickel VM. 1999. NMDAR1 in the caudate-putamen nucleus: ultrastructural localization and co-expression with sorcin, a 22kD calcium binding protein. Neuroscience 90:107-117.
39. Greenough WT, West RV, De Voogd TJ. 1978. Subsynaptic plate perforations: changes with age and experience in the rat. Science 202:1096-1098.
40. Groves PM. 1983. A theory of the functional organization of the neostriatum and the neostriatal control of the voluntary movement. Brain Res Rev 5:109
41. 2 dopamine receptor proteins in the dorsal striatum and their relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237.
42. Hofer M, Constantine-Paton M. 1994. Regulation of N-methyl-D-aspartate (NMDA) receptor function during the rearrangement of developing neuronal connections. Prog Brain Res 102:277-285.
43. Hollman M, Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
44. Horner CH. 1993. Plasticity of the dendritic spine. Prog Neurobiol 41:281-321.
45. Hornykiewick O. 1979. Brain dopamine in Parkinson's disease and other neurological disturbances. In: Horn AS, Korf J, Westerink BMC, editors. The neurobiology of dopamine. London: Academic Press. p 633.
46. Hornykiewick O. 1993. Parkinson's disease and the adaptative capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv Neurol 60:140-147.
47. Hosokawa T, Rusakov DA, Bliss TV, Fine A. 1995. Repeated confocal imaging of individual dendritic spines in the living hippocampal slice: evidence for changes in length and orientation associated with chemically induced LTP. J Neurosci 15:5560-5573.
48. Hsu S, Raine L, Franger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
49. Ingham CA, Hood SH, Taggart P, Arbuthnott GW. 1998. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 18:4732-4743.
50. Jones DG, Harris RJ. 1995. An analysis of contemporary morphological concepts of synaptic remodeling in the CNS: perforated synapses revisited. Rev Neurosci 6:177-219.
51. Kelley JJ, Gao XM, Tamminga CA, Roberts RC. 1997. The effect of chronic haloperidol treatment on dendritic spines in the rat striatum. Exp Neurol 146:471-478.
52. Kemp JM, Powell TPS. 1971a. The site of termination of afferent fibres in the caudate nucleus. Philos Trans R Soc Lond B Biol Sci 262:413-427.
53. Kemp JM, Powell TPS. 1971b. The synaptic organization of the caudate nucleus. Philos Trans R Soc Lond B Biol Sci 262:403-412.
54. Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM. 1992. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol 15:488-500.
55. Kornhuber J, Kornhuber ME. 1986. Presynaptic dopaminergic modulation of cortical input to the striatum. Life Sci 39:699-674.
56. Leranth C, Pickel VM. 1989. Electron microscopic pre-embedding double immunostaining methods. In: Heimer L, Zaborsky L, editors. Tract-tracing methods recent progress. New York: Plenum Press. p 129-172.
57. 2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865.
58. Lidow MS, Wang F, Cao Y, Goldman-Rakic PS. 1998. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse 28:10-20.
59. Mammen AL, Huganir RL, O'Brien RJ. 1997. Redistribution and stabilization of cell surface glutamate receptors during synapse formation. J Neurosci 17:7351-7358.
60. McGeorge AJ, Faull RLM. 1989. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29:503-537.
61. Meshul CK, Casey DE. 1989. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res 489:338-346.
62. Meshul CK, Tan SE. 1994. Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity. Synapse 18:205-217.
63. Meshul CK, Stallbaumer RK, Taylor B, Janowsky A. 1994. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res 648:181-195.
64. Meshul CK, Reassen OA, Allen C, Jorgensen HA. 1996a. Correlation of vacuous chewing movements with morphological changes in rats following one year treatment with haloperidol. Psychopharmacology 125:238-247.
65. Meshul CK, Bunker GL, Mason JN, Allen C, Janowsky A. 1996b. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. J Neurochem 67:1965-1973.
66. 3H]-glutamic acid release by dopaminergic drugs. Life Sci 26:2073-2081.
67. Moghaddam B. 1994. Recent basic findings in support of excitatoy amino acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 18:859-870.
68. Monaghan DT, Bridges RJ, Cotman CW. 1989. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402.
69. Muller M, Gahwiler BH, Rietschin L, Thompson SM. 1993. Reversible loss of dendritic spines and altered excitability after chronic epilepsy in hippocampal slice cultures. Proc Natl Acad Sci USA 90:257-261.
70. O'Dell SJ, La Hoste GJ, Widmark CR, Shapiro RM, Potkin SG, Marshall JF. 1990. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse 6:146-153.
71. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
72. Penney JB, Young AB. 1983. Speculating on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci 6:73
73. Peters A, Palay SL, Webster HD. 1991. The fine structure of the nervous system. New York: Oxford University Press.
74. Petrack B, Emmet MR, Rao TS, Kim HS, Wood PL. 1990. Increases in rat striatal preproenkephalin mRNA levels following chronic treatment with the depot neuroleptic, haloperidol decanoate. Life Sci 46:687-691.
75. Petralia RS, Yokotani N, Wenthold RJ. 1994. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14:667-696.
76. Pickel VM, Johnson E, Carson M, Chan J. 1992. Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. Dev Brain Res 70:75-86.
77. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penny JB, Young AB. 1988. Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci USA 85:5733-5735.
78. Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208.
79. Riva MA, Tascedda F, Lovati E, Racagni G. 1997. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Mol Brain Res 50:136-142.
80. Roberts RC, Gaither LA, Gao XM, Kashyap SM, Tamminga CA. 1995. Ultrastructural correlates of haloperidol induced oral dyskinesias in rat striatum. Synapse 20:234-243.
81. See RE, Chapman MA. 1994. Chronic haloperidol, but not clozapine, produces altered oral movements and increase extracellular glutamate in rats. Eur J Pharmacol 263:269-276.
82. 2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106.
83. Smith AD, Bolam JP. 1990. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci 13:259-265.
84. Standaert DG, Testa CM, Young AB, Penney JBJ. 1994. Organization of N-methyl-D-aspartate glutamate gene expression in the basal ganglia of the rat. J Comp Neurol 343:1-16.
85. Steinhauser C, Gallo V. 1996. News on glutamate receptors in glial cells. Trends Neurosci 19:339-345.
86. Sterio DC. 1984. The unbiased estimation of the number and sizes of arbitrary particles using the disector. J Microsc 134:127-136.
87. Tallaksen-Greene SJ, Wiley RG, Albin RL. 1992. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Res 594:165-170.
88. Tamminga CA, Dale JM, Goodman L, Kaneda H, Kaneda N. 1990. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102:474-478.
89. Toyoda H, Takahata R, Inayama Y, Sakai J, Matsumura H, Yoneda H, Asaba H, Sakai T. 1997. Effect of antipsychotic drugs on gene expression of NMDA receptor subunits in rats. Neurochem Res 22:249-252.
90. Uranova NA, Orlovskaya DD, Apel K, Klintsova AJ, Haselhorst U, Schenk H. 1991. Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse 7:253-259.
91. Waddintong JL. 1990. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431-447.
92. Wang C, Pralong WF, Schulz MF, Rougon G, Aubry JM, Pagliusi S, Robert A, Kiss JZ. 1996. Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. J Cell Biol 135:1565-1581.
93. West MJ. 1993. New stereological methods for counting neurons. Neurobiol Aging 14:275-285.
94. Wickens J. 1988. Electrically coupled but chemically isolated synapses: dendritic spines and calcium in a rule for synaptic modification. Prog Neurobiol 31:507-528.
95. Yamamoto BK, Cooperman MA. 1994. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J Neurosci 14:4159-4166.
96. Yoshida Y, Ono T, Kawano K, Miyagishi T. 1994. Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen. Brain Res 639:139-148.
97. 2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730.
98. Yuste R, Katz LC. 1991. Control of postsynaptic Ca2+ influx in developing neocortex by excitatory and inhibitory neurotransmitters. Neuron 6:333-344.